Hello and welcome to the 2025 Annual Meeting of Stockholders of Rein Therapeutics Inc, which was previously adjourned on June 24, 2025. Please note that today's meeting is being recorded. You can submit questions at any time by clicking on the message icon. It is now my pleasure to turn today's meeting over to Brian Windsor, President and Chief Executive Officer of Rein Therapeutics Inc. Dr. Windsor, the floor is yours.
Good morning and welcome to the 2025 Annual Meeting of Stockholders of Rein Therapeutics Inc. I am Brian Windsor, President and Chief Executive Officer of Rein, and I will be presiding over this meeting. At this time, I call the meeting to order. This year, we are holding our annual meeting in an all-virtual format and are pleased to have everyone join this live webcast. We've designed this meeting to provide stockholders the same rights and opportunities to participate as they would at an in-person meeting. Before we get to the formal business of the meeting, I would like to make some introductions. Joining us at the meeting today are Mr. Josef H. von Rickenbach, our Chairman, and our Director, Dr. Manuel C. Alves Aivado, MD, PhD. Also joining is our management team, Tim Cunningham, Interim Chief Financial Officer.
I would also like to introduce Sharon Ellevold, a representative from Computer Share Trust Company Inc, our transfer agent, and she has been appointed to act as Inspector of Election. In order to conduct an orderly meeting, I call your attention to the rules of conduct posted on the virtual meeting website, which include information about participating in the meeting, including asking questions. Please note that various remarks we make about future expectations, plans, and prospects for the company constitute forward-looking statements for purposes of the Safe Harbor Provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the risk factor section of our most recent annual report on Form 10-K, which is on file with the Securities and Exchange Commission.
In addition, these forward-looking statements represent the company's expectations only as of today. While the company may elect to update these forward-looking statements, it specifically disclaims any obligation to do so. Any forward-looking statements should not be relied upon as representing the company's estimates or views as of any date subsequent to today. I have received an affidavit from the company's transfer agent, Computer share Trust Company N.A., certifying that the notice of the annual meeting and proxy statement were sent to all stockholders of record as of May 5, 2025. Our first order of business at this meeting is to determine whether the shares represented at this meeting, either in person via this virtual meeting or by proxy, are sufficient to constitute a quorum for the purpose of transacting business. Holders of 22,153,736 shares of common stock are entitled to vote at this meeting.
The Inspector of Election has informed me that there are present at this meeting, either in person or by proxy, a total of 9,283,446 shares of common stock, or approximately 41.9% of all shares entitled to vote at this meeting. Therefore, I hereby declare that a quorum exists. Turning now to the items to be voted on at this meeting, as indicated in the notice of meeting and accompanying documents that were made available to stockholders, the first matter to be voted on is the election of one Class II Director to serve for a term expiring at the 2028 annual meeting of stockholders and until his successor is duly elected and qualified. The nominee for election is William C. Ferry. The second and final matter to be voted on is the approval on a non-binding advisory basis of our named executive officer compensation.
If there are any questions on the proposals, they may be submitted on the virtual meeting website. If asking a question, please also include your name and affiliation to the company. Moderator, do we have any questions at this time?
Brian, there are no questions at this time.
Seeing no questions, we'll move on to voting on the proposals. I hereby declare the polls are now open for each matter to be voted upon today. If you have not yet voted, or if you previously voted by proxy and wish to change your vote, you may vote by using the Cast Your Vote link provided on the virtual meeting website and following the instructions there. We will pause briefly to allow the stockholders to vote. Now that everyone has had an opportunity to vote, the business items on the agenda for this meeting are complete and the polls are now closed. Will Sharon Ellevold please tabulate the votes? We now have the preliminary report of the results of the meeting. Based on this report, the nominee for Director has been elected as a Class II Director.
The compensation of named executive officers on a non-binding advisory basis has been approved. The final vote results will be included in the Form 8-K that will be filed within four business days after this meeting. As there is no further business to come before the meeting, I declare the formal part of this meeting adjourned. Good morning.
This concludes the meeting. You may now discuss.